Huaren Pharmaceutical Co., Ltd. (SHE:300110)
2.880
-0.060 (-2.04%)
May 21, 2026, 3:04 PM CST
Huaren Pharmaceutical Market Cap
Huaren Pharmaceutical has a market cap or net worth of 3.4 billion as of May 21, 2026. Its market cap has decreased by -3.03% in one year.
Market Cap
3.40B
Enterprise Value
4.19B
Revenue
1.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.88
Market Cap Chart
Since August 25, 2010, Huaren Pharmaceutical's market cap has decreased from 3.48B to 3.40B, a decrease of -2.07%. That is a compound annual growth rate of -0.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 3.48B | -6.67% |
| Dec 31, 2025 | 3.72B | -10.51% |
| Dec 31, 2024 | 4.16B | -16.59% |
| Dec 29, 2023 | 4.99B | -0.47% |
| Dec 30, 2022 | 5.01B | -11.67% |
| Dec 31, 2021 | 5.67B | 1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qianjiang Yongan Pharmaceutical | 3.63B |
| Nanjing Well Pharmaceutical Group | 3.62B |
| Hunan Hansen Pharmaceutical | 3.56B |
| Zhejiang Cheng Yi Pharmaceutical | 3.54B |
| Tibet AIM Pharm. | 3.48B |
| Harbin Medisan Pharmaceutical | 3.47B |
| Shanghai MicuRx Pharmaceutical | 3.38B |
| Tuoxin Pharmaceutical Group | 3.37B |